Myeloproliferative neoplasms (MPNs) are a group of blood cancers characterized by the overproduction of one or more types of blood cells due to mutations in hematopoietic stem cells. They can lead to complications such as thrombosis, bleeding, and progression to acute leukemia, necessitating careful monitoring and management.